-
-
-
-
-
-
-
Vaxcyte announces $500 million public offering of stock and warrants
-
-
-
-
-
-
-
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Vaxcyte Announces Pricing of $1.3 Billion Public Offering
-
-
-
-
-
-
-
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Vaxcyte Announces Pricing of $600 Million Public Offering
-
72,041 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

